High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis

Journal of Clinical Investigation

Volumn 105, Issue 5, 2000, Pages 653-662

  McCaffrey, Timothy A ^a   Fu, Chenzhong ^a   Du, Baoheng ^a   Eksinar, Sukru ^a   Kent, K Craig ^a   Harry Jr , Bush ^a   Kreiger, Karl ^a   Rosengart, Todd ^a   Cybulsky, Myron I ^c   Silverman, Eric S ^b   Collins, Tucker ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ZINC FINGER PROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; EARLY RESPONSE GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0034060981     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8592     Document Type: Article

References (57)

1. Gashler, A., and Sukhatme, V.P. 1995. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50:191-224.
2. Khachigian, L., and Collins, T. 1997. Inducible expression of Egr-1-dependent genes: a paradigm of transcriptional activation in vascular endothelium. Circ. Res. 81:457-461.
3. Silverman, E., and Collins, T. 1999. Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154:665-670.
4. Khachigian, L., Williams, A., and Collins, T. 1995. Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial-cells. J. Biol. Chem. 270:27679-27686.
5. Silverman, E.S., Khachigian, L.M., Lindner, V. Williams, A.J., and Collins, T. 1997. Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. Am. J. Physiol. 273:H1415-H1426.
6. Khachigian, L., Lindner, L., Williams, A., and Collins, T. 1996. Egr-1 induced endothelial gene expression: a common theme in vascular injury. Science. 271:1427-1431.
7. Biesiada, E., Razandi, M., and Levin, E.R. 1996. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J. Biol. Chem. 271:18576-18581.
8. Kim, S.-J., Jeang, K.-T., Glick, A.B., Sporn, M.B., and Roberts, A.B. 1989. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction. J. Biol. Chem. 264:7041-7045.
9. Kramer, B., Meichle, A., Hensel, G., Charnay, P., and Kronke, M. 1994. Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochem. Biophys. Acta. 1219:413-421.
10. Maltzman, J.S., Carmen, J.A., and Monroe, J.G. 1996. Transcriptional regulation of the ICAM-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: role for transcription factor EGR1. J. Exp. Med. 183:1747-1759.
11. Maltzman, J.S., Carman, J.A., and Monroe, J.G. 1996. Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16:2283-2294.
12. Nair, P., et al. 1997. Early growth response-1-dependent apoptosis is mediated by p53. J. Biol. Chem. 272:20131-20138.
13. Cui, M.Z., et al. 1996. Transcriptional regulation of the tissue factor gene in human endothelial cells is mediated by Sp1 and EGR-1. J. Biol. Chem. 271:2731-2739.
14. Verde, P., Boast, S., Franze, A., Robbiati, F., and Blasi, F. 1988. An upstream enhancer and a negative element in the 5′ flanking region or the human urokinase plasminogen activator gene. Nucleic Acids Res. 16:10699-10716.
15. Haas, T.L., Stitelman, D., Davis, S.J., Apte, S.S., and Madri, J.A. 1999. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J. Biol. Chem. 274:22679-22685.
16. Yan, S.F., et al. 1998. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc. Natl. Acad. Sci. USA. 95:8298-8303.
17. Santiago, F.S., Lowe, H.C., Day, F.L., Chesterman, C.N., and Khachigian, L.M. 1999. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am. J. Pathol. 154:937-944.
18. Santiago, F., et al. 1999. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat. Med. 5:1264-1269.
19. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
20. Ishibashi, S., et al. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
21. Lafyatis, R., et al. 1990. Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription. J. Biol. Chem. 265:19128-19136.
22. Cogswell, P.C., Mayo, M.W., and Baldwin, A.S., Jr. 1997. Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-mduced NF-kappa B1 transcription. J. Exp. Med. 185:491-497.
23. Breslow, J.L. 1996. Mouse models of atherosclerosis. Science. 272:685-688.
24. Ito, M., et al. 1995. Expression of PDGF in relation to cell division in atherosclerotic intima of human carotid arteries. Neurol. Res. 17:345-348.
25. Nagel, T., Resnick, N., Dewey, C., and Gimbrone, M. 1999. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler. Thromb Vasc. Biol. 19:1825-1834.
26. Cui, M., Penn, M., and Chisolm, G 1999. Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1. J. Biol. Chem. 274:32795-32802.
27. Hughes, S.E., Crossman, D., and Hall, P.A. 1993. Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc. Res. 27:1214-1219.
28. Lindner, V., Lappi, D.A., Baird, A., Majack, R.A., and Reidy, M.A. 1991. Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68:106-113.
29. Donovan, M.J., et al. 1995. Neurotropin and neurotropin receptors in vascular smooth muscle cells: regulation of expression in response to injury. Am. J. Pathol. 147:1-16.
30. Aicher, W., Sakamoto, K., Hack, A., and Eibel, H. 1999. Analysis of functional elements in the human Egr-1 gene promoter. Rheumatol. Int. 18:207-214.
31. Russo, M.X., Sevetson, B.R., and Milbrandt, J. 1995. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc. Natl. Acad. Sci. USA. 92:6873-6877.
32. Swirnoff, A.H., et al. 1998. Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol. Cell. Biol. 18:512-524.
33. Svaren, J., et al. 1996. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 16:3545-3553.
34. Silverman, E., et al. 1999. Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury. Am. J. Pathol. 155:1311-1317.
35. Wilcox, J.N., Smith, K.M., Williams, L.T., Schwartz, S.M., and Gordon, D. 1988. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J. Clin. Invest. 82:1134-1143.
36. Nikol, S., et al. 1992. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90:1582-1592.
37. Majesky, M.W., Lindner, V., Twardzik, D.R., Schwartz, S.M., and Reidy, M.A. 1991. Production of transforming growth factor-β1 during repair of arterial injury. J. Clin. Invest. 88:904-910.
38. Wolf, Y.G., Rasmussen, L.M., and Ruoslahti, H. 1994. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J. Clin. Invest. 93:1172-1178.
39. McCaffrey, T., et al. 1999. The expression of TGF-β receptors in human atherosclerosis: evidence for acquired resistance due to receptor imbalance. J. Mol. Cell. Cardiol. 31:1627-1642.
40. Skerka, C., Decker, E.L., and Zipfel, P.F. 1995. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 270:22500-22506.
41. Lin, J.X., and Leonard, W.J. 1997. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol. Cell. Biol. 17:3714-3722.
42. Decker, E.L., Skerka, C., and Zipfel, P.F. 1998. The early growth response protein (EGR-1) regulates interleukin-2 transcription by synergistic interaction with the nuclear factor of activated T cells. J. Biol. Chem. 273:26923-26930.
43. Harrington, M.A., et al. 1993. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem. 268:21271-21275.
44. Chatterjee, S. 1998. Sphingolipids in atherosclerosis and vascular biology. Arterioscler. Thromb. Vasc. Biol. 18:1523-1533.
45. Poston, R.N., Haskard, D.O., Coucher, J.R., Gall, N.P., and Johnson-Tidey, R.R. 1992. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140:665-673.
46. Iiyama, K., et al. 1999. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85:199-207.
47. Ihling, C., et al. 1998. Co-expression of p53 and MDM2 in human atherosclerosis: implications for the regulation of cellularity of atherosclerotic lesions. J. Pathol. 185:303-312.
48. Guevara, N.V., Kim, H.S., Antonova, E.I., and Chan, L. 1999. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat. Med. 5:335-339.
49. de Belle, I., et al. 1999. P53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene. 18:3633-3642.
50. Minc, E., et al. 1999. The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites. J. Biol. Chem. 274:503-509.
51. Huang, R., Fan, Y., Ni, Z., Mercola, D., and Adamson, E. 1997. Reciprocal modulation between Sp1 and Egr1. J. Cell. Biochem. 66:489-499.
52. Kilbourne, E., Widom, R., Harnish, D., Malik, S., and Karathanasis, S. 1995. Involvement of early growth response factor Egr-1 in apoliprotein AI gene transcription. J. Biol. Chem. 270:7004-7010.
53. Silverman, E., et al. 1998. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. Am. J. Respir. Cell Mol. Biol. 19:316-323.
54. Molnar, G., Crozat, A., and Pardee, A. 1994. The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol. Cell Biol. 14:5242-5248.
55. McCoy, C., Smith, D., and Cornwell, M. 1995. 12-o-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by Egr1. Mol. Cell. Biol. 15:6100-6108.
56. Barroso, I., and Santisteban, P. 1999. Insulin-induced early growth response gene (Egr-1) mediates a short term repression of rat malic enzyme gene transcription. J. Biol. Chem. 274:17997-18004.
57. Dinkel, A., et al. 1997. Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B-cells. J. Immunol. 159:2678-2684.